Health Care & Life Sciences » Pharmaceuticals | Sanjivani Paranteral Ltd.

Sanjivani Paranteral Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,585
1,330
1,153
325
180
Cost of Goods Sold (COGS) incl. D&A
1,453
1,260
1,184
342
295
Gross Income
132
70
31
17
116
SG&A Expense
43
31
35
41
418
EBIT
86
40
68
155
534
Unusual Expense
-
-
-
9
-
Non Operating Income/Expense
12
1
5
18
5
Interest Expense
81
79
88
48
4
Pretax Income
30
28
150
175
534
Income Tax
14
4
3
2
3
Consolidated Net Income
16
24
146
173
531
Net Income
16
24
146
173
531
Net Income After Extraordinaries
16
24
146
173
531
Net Income Available to Common
16
24
146
173
531
EPS (Basic)
2.70
4.09
24.82
29.27
89.96
Basic Shares Outstanding
6
6
6
6
-
EPS (Diluted)
2.70
4.09
24.82
29.27
-
Diluted Shares Outstanding
6
6
6
6
-
EBITDA
96
54
55
143
522
Other Operating Expense
-
3
3
97
-
Non-Operating Interest Income
13
11
2
1
-

About Sanjivani Paranteral

View Profile
Address
205, P.N. Kothari Industrial Estate
Mumbai Maharashtra 400078
India
Employees -
Website http://www.sanjivani.co.in
Updated 09/14/2018
Sanjivani Paranterals Ltd. is a research-based, international pharmaceutical company, which engages in the provision of products and services. Its products includes oral solids, small volume parenterals and sterile powder formulations. The company was founded by Anami H.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.